1. Home
  2. SION vs NOA Comparison

SION vs NOA Comparison

Compare SION & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • NOA
  • Stock Information
  • Founded
  • SION 2019
  • NOA 1953
  • Country
  • SION United States
  • NOA Canada
  • Employees
  • SION N/A
  • NOA N/A
  • Industry
  • SION
  • NOA Meat/Poultry/Fish
  • Sector
  • SION
  • NOA Consumer Staples
  • Exchange
  • SION NYSE
  • NOA Nasdaq
  • Market Cap
  • SION 338.0M
  • NOA 399.1M
  • IPO Year
  • SION 2025
  • NOA 2006
  • Fundamental
  • Price
  • SION $12.57
  • NOA $15.94
  • Analyst Decision
  • SION Strong Buy
  • NOA
  • Analyst Count
  • SION 1
  • NOA 0
  • Target Price
  • SION $32.00
  • NOA N/A
  • AVG Volume (30 Days)
  • SION 128.6K
  • NOA 86.5K
  • Earning Date
  • SION 05-25-2025
  • NOA 05-14-2025
  • Dividend Yield
  • SION N/A
  • NOA 1.99%
  • EPS Growth
  • SION N/A
  • NOA N/A
  • EPS
  • SION N/A
  • NOA 1.05
  • Revenue
  • SION N/A
  • NOA $810,226,988.00
  • Revenue This Year
  • SION N/A
  • NOA $11.51
  • Revenue Next Year
  • SION N/A
  • NOA $4.38
  • P/E Ratio
  • SION N/A
  • NOA $15.38
  • Revenue Growth
  • SION N/A
  • NOA 20.85
  • 52 Week Low
  • SION $7.26
  • NOA $13.19
  • 52 Week High
  • SION $25.19
  • NOA $22.08
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • NOA 55.52
  • Support Level
  • SION N/A
  • NOA $15.29
  • Resistance Level
  • SION N/A
  • NOA $15.82
  • Average True Range (ATR)
  • SION 0.00
  • NOA 0.40
  • MACD
  • SION 0.00
  • NOA 0.15
  • Stochastic Oscillator
  • SION 0.00
  • NOA 90.84

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

Share on Social Networks: